Merck Sees Fast Ruling in Johnson and Johnson's Remicade Arbitration

08.09.2010 - Merck said an arbitration panel would look in late September at whether the company is entitled to overseas rights to Remicade and Simponi, Johnson & Johnson's important rheumatoid...